☰
New Zealand reportedly removed most of its remaining COVID-19 restrictions with the government signaling a return to the pre-pandemic era. As reported, people will not have to wear ma...
Read More >>NextGen Healthcare, a leading innovative, cloud-based healthcare technology solutions provider, has recently announced that it plans to apply to become QHIN (Qualified Health Information Network) under the TEFCA (Trust...
Read More >>Toronto-based mental health specialist Braxia Scientific is reportedly planning to acquire KetaMD to expand its telehealth capabilities, especially its tech-based ketamine treatments. The deal is expected to be around ...
Read More >>The Gleneagles Hospital Hong Kong (GHK or Gleneagles) recently held an event to introduce a clinical trial for assessing the security and immunogenicity of Omicron-targeted COVID-19 inactivated vaccine developed by SIN...
Read More >>G42 Healthcare, an AI-powered healthcare company, has reportedly inked an LOI (Letter of Intent) with AstraZeneca, a global science-led biopharmaceutical company, with an intention to enlarge their collaboration into t...
Read More >>Johnson & Johnson (J&J), a global pharmaceutical company, has recently unveiled its new J&J Satellite Center for Global Health Discovery at Duke-NUS Medical School in Singapore. ...
Read More >>Sanford Health, the largest rural healthcare in the U.S, has disclosed plans to expand its orthopedic care with the commencement of a new site of the orthopedic hospital on the 7th of June. As per sources, it will be t...
Read More >>Innovent Biologics, Inc., a biopharmaceutical company that develops, manufacturers, and commercializes top-class medicines, has recently announced the outcomes of high-dose cohorts in Phase 1 clinical study of mazdutid...
Read More >>Owkin, a medical A.I. company, has reportedly secured around $80 million as it gets ready to introduce a drug trial with the American pharmaceutical behemoth Bristol Myers Squibb. ...
Read More >>RoundTable's deep operating expertise will support Polymedco to increase awareness of CRC screening & cardiac testing RoundTable Healthcare Partners, an i...
Read More >>Karkinos plans on using these funds to develop advanced healthcare solutions in India. Under the agreement, Mayo Clinic will be nominating a mem...
Read More >>PROVEN Skincare, the firm that formulates skincare routine specifically for skin, lifestyle, environment, and skin concerns, has recently announced that it has unveiled the first custom-made Eye Cream Duo. ...
Read More >>Indian pharmaceutical company, Glenmark has reportedly introduced a new FDC (fixed-dose combination) of a broadly used Dipeptidyl Peptidase 4 (DPP4) inhibitor, Teneligliptin, with Pioglitazone for people who have type ...
Read More >>Researchers at NIV prove the inefficiency of vaccination in protecting against potential evasion by Omicron variant The Indian Council of Medical Research –...
Read More >>Innovent Biologics, Inc., a biopharmaceutical firm specializing in the development, manufacturing, and commercialization of high-quality medicines, has recently announced IBI322 Phase I study results in patients suffer...
Read More >>Innovent Biologics, a leading biopharmaceutical firm, has revealed Phase-3 clinical trial outcomes of recombinant human anti-PCSK-9 monoclonal antibody in the patients with HeFH (heterozygous familial hypercholesterole...
Read More >>COVID-19 infections have risen again in the U.K. following easing restrictions and fast spread of the more-transmissible omicron subvariant. As per latest reports, more than 574,000 peo...
Read More >>Innovent Biologics, Inc., a biopharmaceutical firm dedicated to developing, commercializing, and manufacturing high-quality medicines, has extended its partnership with Eli Lilly and Company given to their shared commi...
Read More >>Everest Medicines, a late clinical-stage biopharmaceutical company that focuses on developing and commercializing pharmaceutical products in the APAC region, recently announced entering into a licensing agreement with ...
Read More >>The acquisition is expected to boost Agilent’s digital capabilities for enhancing lab productivity American instrument manufacturing company, Agilent Technolo...
Read More >>The United States Food & Drug Administration (FDA) has granted emergency use authorization (EUA) to an antibody drug, dubbed bebtelovimab, developed by American pharmaceutical giant, Eli Lilly & Company to comb...
Read More >>Sputnik Light Vaccine becomes the ninth vaccine against COVID-19 in India with DCGI approval The Drugs Controller General of India (DCGI) has approved emergency use...
Read More >>Can Fite BioPharma, an advanced clinical stage biotechnology company ramping up pipeline of its proprietary small molecule drugs designed for inflammatory, cancer and liver diseases, has reportedly announced the enroll...
Read More >>Galvani Bioelectronics, a clinical-stage bioelectronics R&D company, recently announced the first successful treatment of a Rheumatoid Arthritis (RA) patient by stimulation of the splenic nerve done via its novel b...
Read More >>The new Omicron variant has shifted the pandemic into a new phase and could end in Europe, claims WHO Europe Director Hans Kluge recently. Mr. Kluge told sources that it could be po...
Read More >>Eka Care, a digitally enabled and connected healthcare ecosystem for better health outcomes, is now helping citizens book vaccination slots for children aged 15 to 18 years. The vaccination drive for teenagers has been...
Read More >>World Health Organisation’s (WHO) Regional Director for Europe, Hans Kluge has reportedly stated that new drugs developed against COVID-19 will intensify the survival rate for patients suffering from severe COVID...
Read More >>Antiviral pills by Pfizer consisting of two drugs is undergoing scrutiny as one of it is suspected to cause severe interactions with some of the widely used prescriptions such as blood thinners, statin and antidepressa...
Read More >>The French health authority has been reluctant to authorize Merck’s Covid antiviral pill France has called off its order for Covid antiviral drug developed b...
Read More >>As per recent data by the World Health Organization (WHO), the Omicron variant is spreading rapidly compared to the Delta variant and is causing infection in people who are now vaccinated or who have recovered earlier ...
Read More >>As UK witnesses a record spike in number of new COVID cases linked with the Omicron variant, researchers in the country are using new methods for quickly developing and mass-producing the mRNA vaccines and therapeutics...
Read More >>Ramsay Health Care, an Australian healthcare giant, has unveiled plans to buy Elysium Healthcare, a leading mental health service provider in UK, for $1.4 billion. Ramsay is optimis...
Read More >>Korean bio-venture, 3bigs, has recently announced developing a big data platform for genome therapy and drug development in association with Amazon Web Services (AWS). As per credible s...
Read More >>Cartula Health India, India’s foremost telemedicine startup which intends to revolutionize healthcare across India, has recently announced an innovative service sponsored by Medway Technologies - an AI-powered pl...
Read More >>Soaring coronavirus cases have broken past records in Europe, once again putting the continent at the epicenter of the pandemic. As a result of unprecedented events, health experts ...
Read More >>GlycoMimetics, Inc., a firm that develops molecule drugs, has recently announced that biotech company Apollomics has dosed first patient in China in a Phase 3 clinical trial of its new relapsed or refractory acute myel...
Read More >>Chinese biotechnology company, Ascletis Pharma Inc. has entered into a worldwide license agreement with Suzhou Alphamab Co., Ltd., outside Greater China for ASC22 (Envafolimab) for the treatment of all viral diseases i...
Read More >>Renowned orthodontic solutions provider, LightForce Orthodontics has reportedly secured $50 million in a Series C financing round led by Kleiner Perkins along with participates including Tyche Partners, AM Ventures and...
Read More >>Antengene Corporation Limited, a leading biopharmaceutical company, has successfully received approval from the US FDA (Food and Drug Administration) for Investigational New Drug (IND) application of ATG-101, a potenti...
Read More >>FINVASIA, an Indian fintech company, has recently announced that it has acquired Gini Health, a personalized health & nutrition company based in Canada. The move is in line with FINVASIA’s plan to s...
Read More >>Renowned pharmaceutical company, Novartis has recently disclosed that its lung cancer drug ‘canakinumab’ has failed again in meeting its goal of improving overall survival rates in lung cancer patients and ...
Read More >>Abbott’s partnership with Real Madrid will cater to children’s education, social welfare, sports activities in around 80 countries It ...
Read More >>New Zealand is preparing for an increase in Covid-19 cases after registering 94 new infections over the weekend, with pandemic modelers predicting that if the government continues on its present path, new cases would r...
Read More >>Pharma majors, Pfizer and BioNTech have recently requested the FDA to approve emergency use of their coronavirus vaccine for children aged between 5 to 11. If approved, the vaccine rollout could potentially protect mor...
Read More >>Genomic Vision, a molecular diagnostics and technology company that develops tools and services focused on examining and controlling changes in the genome, has recently announced the unveiling of TeloSizer®, an adv...
Read More >>Innovent Biologics, Inc., a biopharmaceutical company, and AnHeart Therapeutics Co., Ltd. have jointly announced interim clinical data from a Phase 2 trial (TRUST) evaluating Taletrectinib (AB-106), an investigational ...
Read More >>Alan, a health insurance startup based in France, has acquired American digital behavioral health firm, Jour for $20 million. The acquisition has assisted the French health insurer to launch its new digital health...
Read More >>American healthcare company, CVS Health Corp. says that it will hire up to 25,000 people for clinical and retail job positions ahead of the flu season at a time when administration of booster COVID-19 vaccination jabs ...
Read More >>Clinicy, an innovative healthtech firm based in Saudi Arabia, has roped in a seven-figure funding from Mad'a Investment Company, a private equity firm headquartered in Riyadh. While the specific amount of the inves...
Read More >>The COVID-19 pandemic has drawn light to some key challenges faced by Hispanic communities in the U.S. to access healthcare services. Aiming to offer personalized health services to these communities, digital healthcar...
Read More >>Leading vaccine developers, Pfizer and BioNTech have recently submitted primary stage clinical data to the U.S. FDA (Food and Drug Administration) as a part of their efforts to authorize booster vaccine shot for COVID-...
Read More >>The U.S. FDA (Food and Drug Administration) has revised the emergency use authorizations (EUA) status of the Pfizer and Moderna Covid-19 vaccines to permit people with weakened immune systems to receive its third dose....
Read More >>Zydus Cadila, an Indian pharmaceutical company, has reportedly approached the top drug regulator in the country to seek restricted emergency approval of its 3-dose COVID-19 vaccine, ZyCov-D. ...
Read More >>Elevating cases of chronic hepatitis B (CHB) has now impelled Asceltis Pharma Inc., a data driven biotech firm in China, to experiment towards developing drugs that can, to some extent, reduce the impact of CHB in the ...
Read More >>HighTide Therapeutics, a clinical-stage biopharmaceutical entity that focuses on the development of new therapies for the treatment of gastrointestinal diseases, chronic liver illnesses, and metabolic disorders, has an...
Read More >>The US Food and Drug Administration has finally produced a green flag to EndoFresh’s novel Disposable Digestive Endoscopy System following years of reports of persistent cross-contamination issues transmitted in ...
Read More >>The U.S -based InVita Healthcare Technologies has recently announced investing an undisclosed amount in STACS DNA, a prominent leader in sexual assault kit tracking and software provider. ...
Read More >>While India is currently facing the wrath of the second wave of corona-virus due to acute shortage of oxygen concentrators, various companies have forward to help the country get back on track. Amongst these are Hydera...
Read More >>India's first mRNA-based COVID-19 vaccine, HGCO19, formulated by Pune-based biotech firm, Gennova Biopharmaceuticals is about to enter its Phase 1/2 clinical trials with the enrollment of candidates, said the Department of Biotechnology (DBT)....
Read More >>Adverum Biotechnologies, a California based biotech company, has reportedly announced new clinical data from the OPTIC Phase 1 with dose ranging clinical stage trial of gene therapy intravitreal injection namely ADVM-022. The OPTIC trial h...
Read More >>The biopharmaceutical giant has also received a USD 10 million development milestone payment from Merck & CO. for the initiation of the trial A clinic...
Read More >>Premier Inc., a renowned healthcare improvement company, has reportedly announced that it has entered a definitive agreement to purchase certain liabilities and all the assets of Nexera, Inc. and Acurity, Inc., two who...
Read More >>TherapeuticsMD, Inc., an inventive pharmaceutical company that focuses on women healthcare, has recently announced that it has presented a New Drug Application (NDA) pre-approval efficacy supplement to the U.S. FDA (Fo...
Read More >>Cerevel Therapeutics, LLC, a biopharmaceutical company developing new therapies for treating neuroscience diseases, has reportedly dosed healthy volunteers in Phase 1 clinical trial of CVL-936, a potential first-in-cla...
Read More >>NextGen Healthcare, a renowned electronic health record software developer, reportedly announced its exclusive collaboration with Doctible, a platform that allows healthcare providers to gain real-time feedback from th...
Read More >>Syros Pharmaceuticals, a leading biotechnology company focused upon developing medicines for controlling and altering expression of genes, recently announced that the first patient has been dosed in the clinical trial ...
Read More >>Nabis Holdings Inc., is apparently thinking of inking a joint venture (JV) with the Israel company Panaxia Pharmaceutical Industries, Ltd. Reportedly, the MOU signed between the two companies mandates Panaxia to offer ...
Read More >>NantHealth, Inc., a personalized, evidence-based, next-generation healthcare company and NantOmics, LLC, one of the leading companies in molecular analysis, have reportedly launched an innovative AI platform for assist...
Read More >>Genentech, Inc., a subsidiary of the Roche Group, has reportedly announced the completion of a sBLA (supplemental Biologics License Application) submission to the U.S. FDA (Food and Drug Administration) for Tecentriq &...
Read More >>The U.S. Food and Drug Administration, an agency within the U.S. Department of Health and Human Services, recently issued a safety communication informing patients, health care providers and facilities regarding t...
Read More >>A clinical stage biotechnology company, PDC*line Pharma, focused upon developing a new class of effective and scalable active immunotherapies for treating cancers, recently announced completion of a Series B ...
Read More >>Findings from the study are being produced at the 17th Annual Winter Clinical Dermatology Conference in Kohala Coast The data indicated ...
Read More >>Amidst all the recurring headlines of patients complaining about expensive medicines and treatments, EQRx, a novel biotechnology company, has comes up with plans to create novel, patent-protected drugs at affordable pr...
Read More >>A clinical-stage biopharmaceutical company, Oyster Point Pharma, Inc. recently announced positive results from its Phase 2 MYSTIC clinical study for Dry Eye Disease. For the record,...
Read More >>Agenus Inc., a U.S. based immuno-oncology firm, has announced that it has started dosing its first patient with AGEN1223, a novel bi-specific antibody developed to reduce regulatory T cells in the tumor microenvironmen...
Read More >>The biopharmaceutical firm reported positive results from the PEOPLE Phase-3 study of Viaskin Peanut in the children suffering from the peanut allergy. ...
Read More >>B-SIMPLE2 trial was statistically considerable for numerous pre-specified sensitivity analyses. Similar assessments with B-SIMPLE1 showed reasonably supportive and consistence results of B-SIMPLE2....
Read More >>Radiologists miss nearly 20% of breast cancer spotting in mammograms Google’s AI technology is developed with Alphabet Inc.’s DeepMind AI As per a latest ...
Read More >>Principia Biopharma Inc. recently updated about the anticipated timings for the final result from the ongoing trial of PRN1008 data in patients suffering from pemphigus, along with CRR (complete response rates) from it...
Read More >>Digital Ally Inc., a manufacturer and marketer of innovative video recording products for emergency management, law enforcement, fleet safety, and security has reportedly announced its partnership with Pivot Internatio...
Read More >>The new definitive agreement would allow Stem to foray into the lucrative California dispensary market." After successful comple...
Read More >>The U.S. FDA (Food and Drug Administration) has reportedly made headlines after it recently approved the first generic versions of Eliquis (apixaban) tablets in the U.S. The generic tablets are formulated to ...
Read More >>BeiGene, Ltd., a China based biopharmaceutical company, that focuses on developing and commercializing immuno-oncology and molecularly targeted drugs to treat cancer, has reportedly announced that the NMPA that is Nati...
Read More >>A clinal stage life science company, Eleusis recently announced results from the Phase 1 clinical trial of LSD (Lysergic Acid Diethylamide), demonstrating the potential of the orally administered low doses of the drug ...
Read More >>The Federal Trade Commission, commonly abbreviated as FTC has blocked the acquisition of Pacific Biosciences (PacBio) by its established rival Illumina. Illumina is a leading biotechnology company specializing in manuf...
Read More >>GlaxoSmithKline, a UK-based pharmaceutical company recently announced treatment of patients with heavily pre-treated multiple myeloma with belantamab mafodotin, an investigational agent. The study resulted in a clinica...
Read More >>The results from the clinical study rendered no change from baseline in dystrophin expression Clinical stage genetic medicines company- Wave Life Sciences Ltd. has ...
Read More >>Roche Holding, a renowned Swiss healthcare company working in pharmaceuticals and diagnostics, reportedly announced novel data from its Phase 3 FeDeriCa trial. The trial showed the investigational FDC (fixed-dose combi...
Read More >>Biothera Pharmaceuticals, Inc., a renowned Minnesota based biotechnology company, reportedly announced that clinical benefit data and updated response from its Phase 2 study in chemo-refractory mTNBC (metastatic triple...
Read More >>argenx, a renowned Netherlands based biotechnology firm, reportedly announced the publication of outcomes from the assessment of its FcRn antagonist, efgartigimod, in a Phase 2 ITP clinical trial, in the American Journ...
Read More >>Kaman Composites Vermont, also known as KCV and a subsidiary of Kaman Corporation, a renowned aerospace company, reportedly announced a manufacturing contract with Carestream Health, an independent subsidiary of Onex C...
Read More >>Chronic lymphocytic leukemia (CLL) is a common type of adult leukemia. In the United States, it is estimated that more than 20,000 new cases of CLL will be diagnosed in 2019. With an eye to cure CLL, biotechnology comp...
Read More >>Co-Diagnostics, a renowned US-based molecular diagnostics company, having a patented, unique platform to develop diagnostics tests reportedly announced that CoSara Diagnostics, the company’s JV for production, ha...
Read More >>NantKwest Inc., a U.S.-based clinical-stage immunotherapy company, has reportedly announced encouraging safety data generated from the first six patients in its QUILT-3.064 clinical trial. The study is conducted t...
Read More >>Japan’s research-based pharma company, Chugai Pharmaceutical Co., Ltd. has recently made it to headlines when it agreed to change the equity structure of C&C Research Laboratories (C&C), a Korea...
Read More >>Clover Biopharmaceuticals, a renowned research-based, clinical-stage biotechnology firm, reportedly announced that it has closed a $43 million Series B investment round. The investm...
Read More >>Cinda Biopharmaceutical, a startup that focuses on treating autoimmune and metabolic diseases, has recently announced the completion of its Phase I clinical study of human epidermal growth factor receptor-2 (HER2) and ...
Read More >>TFF Pharmaceuticals, Inc., claims that it has initiated Voriconazole Inhalation Powder’s phase 1 clinical trial —Voriconazole’s inhaled dry powder version that is direct-to-lung and complements next-g...
Read More >>The company’s drug candidate DNX-2401 in combination with Pembrolizumab depicted clinical benefit in brain tumors like Recurrent Glioblastoma. ...
Read More >>Clinical-stage immunotherapy firm Harpoon Therapeutics & biopharma company AbbVie Inc have reportedly announced a collaboration to obtain a global license for HPN217. HPN217 is a BCMA (B cell maturation antigen) - ...
Read More >>QIAGEN N.V., a leader in molecular diagnostics and pharmaceutical research, recently revealed a new agreement with North Carolina based LabCorp® to extend its Clinical Insights (QCI) license with its Human Gene Mut...
Read More >>The data shows a major statistical improvement in coronary flow reserve Single-use CLBS16 can reportedly improve heart function and s...
Read More >>BRUKINSA is the first product from BeiGene to get approval from the FDA 84% of patients who are talking BRUKINSA have achieved an ORR...
Read More >>The ongoing clinical trial of DCC-3014 have shown preliminary anti-tumor activity. DCC-3014 validates emerging tolerability profile...
Read More >>Merck will pay up to $576 million for the acquisition Preclinical TRPML1 has the potential to treat neurodegenerative and lysosomal d...
Read More >>The new launch of the services will help the company expand its oncology portfolio Personalis has been able to sequence more than 40...
Read More >>Spinal muscular atrophy (SMA) is a genetic neuromuscular condition, affecting approx. 1 in 6,000 babies born globally each year. Numerous healthcare companies throughout the world are putting their best foot fo...
Read More >>Celltrion Healthcare, a biopharmaceutical company, recently announced data from a study further investigating efficacy, safety, immunogenicity & pharmacokinetics of CT-P13 SC, over a period of 1-year treatment. The study focuses on the results...
Read More >>AML (acute myeloid leukemia), a severe, life-threating disease that is one of the most common causes of cancer-related death. Common treatment options for this condition includes stem-cell transplants, chemotherapy and...
Read More >>Vascular diseases are commonly termed as any abnormal condition that arises in the blood vessels (veins and arteries) which can lead to severe disability or death. Currently, there are several treatment alternativ...
Read More >>Myocardial infarction (MI), commonly known as heart attack, occurs due to decrease in blood flow that damages heart muscles. Currently, MI treatment varies from making changes in lifestyle to medication and bypass...
Read More >>Agile Therapeutics, Inc., a renowned New Jersey based women’s healthcare and pharmaceutical company, has reportedly announced the positive outcome of a recent U.S. FDA Bone, Reproductive and Urologic Drugs Adviso...
Read More >>Duchenne muscular dystrophy (DMD) approximately affects 1 in every 3,500 male births every year in the world. several biopharmaceutical and biotechnology firms across the globe are increasingly working towards the disc...
Read More >>Insomnia associated with alcohol cessation (IAAC) is a major challenge faced by patients who are recovering from AUD (alcohol use disorder), struggling to achieve sustained abstinence from alcohol. Given the massive op...
Read More >>Various hereditary disorders and diseases are increasingly growing across the world which need to be treated effectively. Global pharmaceutical firms are increasingly working towards finding novel solutions to address ...
Read More >>Leading specialty generic pharmaceutical company Sun Pharmaceutical Industries Ltd has reportedly announced the launch of CEQUA (cyclosporine ophthalmic solution) 0.09% in the US by one of its subsidiaries. ...
Read More >>Ophthalmic device usage and production are projected to witness an exponential growth in the near future due to the growing prevalence of eye conditions. Various pharmaceutical firms across the world are increasingly t...
Read More >>Autoimmune diseases are on a rise in today’s fast-paced world. Rheumatoid arthritis (RA) is one such clinical condition in which a patient’s immune system attacks its own tissue, including joints. In m...
Read More >>Cancer treatment is one of the biggest challenges for the 21st century. There have been many advancements in the field of cancer treatment over the past few years. Clinical trial indeed plays a pivotal role in discover...
Read More >>Number of cases where people are affected with neurodegenerative diseases have been growing at a substantial pace. Alzheimer’s disease and Parkinson’s disease are the most common neurodegenerative diseases ...
Read More >>Non-alcoholic Steatohepatitis (NASH) is a progressive disease which can ultimately lead to cirrhosis and liver failure. Liver transplantation is the only treatment for managing advanced cirrhosis with liver failure. Th...
Read More >>Owing to widescale tobacco use, the world is seeing an increased number of cancer and vascular diseases. India alone registers more than 10 million cases of peripheral artery disease on an annual basis. Technology and ...
Read More >>SMA is a rare genetic disease that typically affects young children. Currently, there is no cure for spinal muscular atrophy (SMA), however, various pharmaceutical firms across the world are working to discover a novel...
Read More >>Colorectal cancer (CRC), also known as bowel or colon cancer, is a type of cancer that involves abnormal growth of cells that can invade or spread to other parts of the body. Growing prevalence of CRC has led...
Read More >>Lately, Carcinogens have found their way into the generic drug supply of the United States. In 2018, FDA found NDMA, a probable carcinogen for humans, in the widely-used valsartan tablets due to the impurities it had i...
Read More >>Today, people across the world are prone to numerous health disorders, and cancer is one of the major diseases which is growing at an alarming rate. Researchers around the world are putting their best foot forward to d...
Read More >>sarcoma is a type of bone cancer that can also appear in fat, muscle, deep skin tissues, blood vessels, tendons, ligaments and cartilage. Moreover, there are over 70 types of sarcoma, with each treatment vary...
Read More >>Chronic immune thrombocytopenia (ITP) is a disorder in which the body’s immune system destroys platelets which play a key role in blood clotting and healing. Currently, therapies such as steroids and splenectomy ...
Read More >>limb spasticity is a disorder that hampers the movement of the arms by stiffing the muscles. Spasticity is a result of the body’s damaged nervous system, which generally occurs due to disease, inju...
Read More >>Colorectal cancer, also known as colon cancer, rectal cancer or bowel cancer, affects a patient’s rectum and colon. Reportedly, it is the third most common type of cancer detected in both women and men ...
Read More >>TTP399 increased Time in Range, reduced hyperglycemia time, a bolus insulin dose that was lower and fewer hypoglycemic events. TTP399...
Read More >>KCNQ2 epileptic encephalopathies is a serious type of neonatal epileptic condition which manifests in newborn children during the first week if their lives. This disease is being addressed by various pharmaceutical com...
Read More >>With growing population of diabetic patients, diabetes management is becoming a daunting activity. Sugar level management and insulin injections tracking is a difficult work. Thus, leading pharmaceutical companies are ...
Read More >>The healthcare company will showcase its drugs in the ASTRO annual meeting 2019 that could help offer improved efficiency and confidence in treatment delivery. Ake...
Read More >>The drug was well tolerated and was safe, and has shown the capacity to improve the treatment paradigm for patients with wet AMD. Adverum Biotechnologies, Inc., a c...
Read More >>The company plans to join various institutions in order to accomplish its new medical studies which focus on hearing, women’s health and mobility. Apple Inc.,...
Read More >>The manuscript includes data of the first four trial participants that were treated with RP-L102 under the Phase 1/2 FANCOLEN-I study. ...
Read More >>INBRX-101 is built to provide greater clinical activity to pdAAT by offering sustained improved concentration of plasma within a less frequent, regimen of monthly dosing. &nb...
Read More >>The data from the neuroscience portfolio would be showed at the 35th ECTRIMS between September 11 and 13 in Stockholm. The...
Read More >>The electronics giant is looking forward to putting forth the next-generation of its Smart Imaging Platform to offer hospitals a streamlined digital imaging work-flow. ...
Read More >>The pharmaceutical company declared the completion of CTN submission to Japanese PMDA for TLX250-CDx. It is permitted to conduct Phase trials for r...
Read More >>The trial focuses on the effects of Prexigebersen when combined with Decitabine and Venetoclax on AML patients. Bio-Path Holdings, Inc., a biotechnology company ren...
Read More >>Leading biopharmaceutical expert CStone Pharmaceuticals has reportedly announced the first person in China to be dosed for the Phase I/II bridging trial of Avapritinib, discovered by Blueprint Medicines, a partner of C...
Read More >>The pharmaceutical company has entered into an agreement with China Medical System Holdings to manufacture and manage 7 generic products in Mainland China. ...
Read More >>Data from the Phase 2 Onvansertib clinical trial will be presented at the 20th Prostate Cancer Conference. The trial asses...
Read More >>Outputs from single ascending dose specify that TERN-201 is well tolerated and generally safe & can inhibit plasma SSAO activity. ...
Read More >>Zolgensma is specifically designed to be given to children below the age of two years with SMA. The FDA acknowledged that there were ...
Read More >>The study cites that dosing with GRF6019 were harmless and well-tolerated in patients with Alzheimer’s disease dementia (AD). Alkahest, Inc.,...
Read More >>PRGN-3005 UltraCAR-T is a type of multigenic CAR-T cell therapy which utilizes Precigens advanced non-viral gene delivery system Precigen Inc, a biopharmaceutical compa...
Read More >>· Patients enrolled to the clinical trial were given 1.0 mg of sham injection or risuteganib. · It would not be a helpful treatment for all pa...
Read More >>The study will evaluate the tolerability and safety of TJD5 and determine recommended doses for future clinical studies. I-Mab Biopharma (I-Mab), a...
Read More >>The trial involves patients diagnosed with acute myeloid leukemia and colorectal, ovarian, triple negative breast and small cell lung cancers. SELLAS Life Sciences...
Read More >>Mylan holds a market value worth $9.5 billion and has witnessed almost 50% fall in its shares over the last year Pfizer Inc., a multinational pharmaceutical company...
Read More >>New findings come from evaluation of Doravirine combined with Islatravir versus DELSTRIGO. The company plans to start Phase 3 trials ...
Read More >>The FDA warning had come after Curaleaf made unsubstantiated claims that their CBD (cannabidiol) based products can treat serious diseases. ...
Read More >>The Phase 1b clinical trial can accelerate HQP1351’s clinical development program globally Ascentage Pharma, a biotechnology company that is involved in the d...
Read More >>Ambrx will receive additional development payments with Bristol-Meyers’ initiation of the Phase 1 clinical trial for Relaxin Ambrx Inc., a biopharmaceutical c...
Read More >>The transaction will be LifeSpan BioSciences’ second investment this year following its Nordic-MUbio acquisition LifeSpan BioSciences (LSBio), a provider of l...
Read More >>AbbVie Inc., a US-based pharmaceutical company recently announced acquisition of Mavupharma, a Seattle-based biopharmaceutical company, which is focused on innovative strategies to target the STimulator of INterferon G...
Read More >>Ligand Pharmaceuticals, a US-based biopharmaceutical company recently announced positive top line results from clinical trial of its internal CE (Captisol-enabled) Iohexol program. The study attained primary endpo...
Read More >>The study is formulated to evaluate the safety and efficacy of Oral KORSUVA for moderate to severe pruritus Biopharmaceutical firm Cara Therapeutics Inc. has report...
Read More >>The company would be able to supply and commercialize its biosimilar across Russia under the latest of the two deals. The second deal...
Read More >>DHOR had been administering Parkview under a management and operations transfer agreement as of February 2019 whilst waiting for HUD approval. Doctors Hospital of R...
Read More >>Octapharma has reportedly presented an update on the clinical development and pre-clinical data of SubQ-8 in a conference at the International Society on Thrombosis and Haemostasis Congress 2019. SubQ-8 integrates a hu...
Read More >>Onco360 will be able to support specialized needs of RRMM patients and their physicians across all the U.S. states The largest independent oncology pharmacy in U.S....
Read More >>The innovaTIL-04 study is anticipated to register a total of 75 to 100 patients with the aim to support a BLA submission Reports confirm that Iovance Biotherapeutic...
Read More >>The agreement gives Grupo RPH exclusive right to manufacture and distribute the TLX591-Cdx in the Latin American market Clinical-stage biopharmaceutical firm Telix ...
Read More >>It had earlier informed it will withdraw its investment in Arrow Pharmaceuticals for an agreed price of AUD 394 million Reports confirm that Strides Pharma Science,...
Read More >>The 26-week observational study included 16 subjects at three different hospitals in the UK Global regenerative medicine company AVITA Medical has recently announce...
Read More >>Controlled IL-12 platform from Ziopharm is an investigational gene therapy designed to control and induce human interleukin 12 production Ziopharm Oncology Inc, a c...
Read More >>PD-L1 t-haNK is a natural killing cell-based immuno-oncology therapy which includes Chimeric Antigen Receptor (CAR) based on PD-L1 NantKwest, leading company in cli...
Read More >>Parexel stands as a pioneer in the delivery and development of a wide range of FSP, with full and flexible clinical development services Parexel, a leading global ...
Read More >>Within forty days of closure of the acquisition, UnitedHealth Group would divest DaVita Medical Group’s healthcare provider in Las Vegas UnitedHealth Group ha...
Read More >>RP-A501 gene therapy can make a significant difference in patients who are suffering from Monogenic Heart Failure Syndrome Rocket Pharmaceuticals Inc, a multi-platf...
Read More >>BioNTech SE, the largest privately held biopharmaceutical company in Europe, recently announced initiation of first-in-human study of DuoBody-PD-L1x4-1BB for the treatment of solid tumors, cite sources. ...
Read More >>A clinical-stage immune-oncology company, Forty Seven, Inc., that works to develop therapies targeting cancer immune evasion pathways, has revealed clinical data from Phase 1b/2. The company is evaluating a new drug co...
Read More >>Progenics Pharmaceuticals, Inc., a biopharmaceutical company, has recently announced that its first patient has been dosed for treatment of Metastatic Prostate cancer, in a phase 2 clinical study of 1095 radiotherapy. ...
Read More >>NuCana is on its way to open a Global Phase III study of Acelarin in combination with cisplatin for patients who are suffering from the disease in 2019 NuCana plc r...
Read More >>A US-based pharmaceutical company, Aerpio Pharmaceuticals, Inc., recently announced the initiation of Phase 1b clinical trial of AKB-9778 to develop treatment of PAOG (primary open angle glaucoma), report sources. ...
Read More >>Polivy is an innovative antibody-drug conjugate developed with an intention of targeting specific cells Reports confirm that the US Food and Drug Administration has...
Read More >>The new data further supports the potential of Dance 501 inhaled insulin in Type 2 diabetes patients Dance Biopharm Holdings, Inc has recently presented Phase 2 Sam...
Read More >>A clinical stage oncology drug development company Xynomic Pharmaceuticals Holdings, Inc. has reportedly announced that it has dosed the first patient in a Phase 1/2 trial. Apparently, the trial combines abexinostat wi...
Read More >>· The company announced that the clinical trial failed to fulfil the first of the two preestablished endpoints. · Citing the result of the ana...
Read More >>Clinical stage biopharmaceutical company American BriVision has reportedly released positive outcomes of its ABV-1504 Phase II clinical trial, under Taiwan FDA clinical protocol code of BLI-1005-002 and the U.S. Food a...
Read More >>Clinical-stage biopharmaceutical company Mersana Therapeutics, Inc. has reportedly presented interim efficiency and safety data from its current Phase 1 dose-escalation study evaluating its first-in-class ADC candidate...
Read More >>Every subject received one dose of RGX-314 managed by subretinal delivery. The leading clinical-stage biotechnology company REGENXBIO Inc. has recently announced that i...
Read More >>Preliminary outcomes of the first part of the study have been made available and results of the second part are anticipated to be published in the third quarter of this year. ...
Read More >>MIJ821 is a potent and selective NMDA receptor modulator being developed for the treatment of treatment-resistant depression Cadent Therapeutics, a precision neuros...
Read More >>A clinical-stage biopharmaceutical company, 89bio LTD that focusses on NASH (nonalcoholic steatohepatitis), liver and other metabolic disorders, recently announced positive results from Phase 1 SAD (single ascending do...
Read More >>Both acquisitions are good cultural & strategic fit and meet the company’s financial hurdle rates while further expanding its current capabilities. ...
Read More >>The company is looking forward to enrolling patients with desmoid tumors to confirm the clinical benefits of nirogacestat SpringWorks Therapeutics, a clinical-stage...
Read More >>The two firms will bring forth single-use endoscopes to patients undergoing ERCP procedures to reduce the risk associated with serious cross-contaminations. Medical...
Read More >>The exclusive license & option agreement has been signed for a new Antibody-Drug conjugate program. The program, named ICON-2, sp...
Read More >>These tablets are indicated for nasal decongestant and antihistamine Unichem may produce and market the generic drug products after approval ...
Read More >>Roche’s new detection kits have more translucent dyes which are suited for mRNA ISH co-localization studies Swiss healthcare company Roche has recently announ...
Read More >>The NDAs are for oral therapies developed as medication for patients with raised LDL-C who require additional LDL-C lowering Esperion has recently announced that th...
Read More >>Brilacidin oral rinse is supposedly being developed as part of FDA Fast Track designation for Oral Mucositis Reports confirm that Innovation Pharmaceuticals, a clin...
Read More >>Clinical stage biopharmaceutical company Cerevance has reportedly completed its Phase 1 clinical trial of CVN424, the company’s first-in-class, oral drug in development for treating Parkinson’s disease. The...
Read More >>AstraZeneca & Merck’s LYNPARZA has reportedly received a positive opinion from the EMA’s (European Medicine Agency) CHMP (Committee for Medicinal Products for Human Use), for the first-line maintenance ...
Read More >>Drug development company, Belite Bio’s Investigational New Drug application for LBS-008 (BPN-14967), developed to treat AMD and Stargardt disease, has reportedly been approved by the U.S. Food and Drug Administra...
Read More >>Innovent Biologics, Inc., a top-notch biopharmaceutical firm which produces and commercializes superior quality medications, has recently declared that the first patient has successfully been dosed in China in the Phas...
Read More >>Cortexyme, Inc. has reportedly launched the GAIN Trial, a worldwide Phase 2/3 clinical trial of COR388, the company’s lead investigational drug, in patients suffering from mild to moderate Alzheimer’s disea...
Read More >>The results from the SC+ HFT with patients as well as healthcare professionals prove that SC+ is easy to use even with a significant learning decay period and minimal training. ...
Read More >>Results from the trial are expected in the first half of 2020 and the information would be used to design and plan any further clinical development Biopharmaceutica...
Read More >>Regeneron Pharmaceuticals Inc. and Alnylam Pharmaceuticals Inc. have reportedly entered into a definitive collaborative deal. Authentic sources claim that the deal has been inked in a major effort to discover, advance ...
Read More >>The strategic partnership is aimed at jointly developing a new immuno-stimulatory therapy for certain neurologic disorders. I-Mab Biopharma, a Shanghai-based biotec...
Read More >>A joint venture will combine IPS Specials’ abilities as a licensed pharma importer with medical cannabis expertise of Grow Biotech Reports confirm that IPS Sp...
Read More >>New data describes that a combination of Innate’s anti-CD39 monoclonal antibody and ATP-inducing oxaliplatin had enhanced the control of tumor growth Innate P...
Read More >>The FDA (Food & Drug Administration) has reportedly proposed a new rule that would require mammography providers to inform female patients with dense breast tissue about the fact that the condition may impact the a...
Read More >>The deal is expected to be closed in first half of this year Financial terms of the deal were not disclosed yet ...
Read More >>AR-1105 is an intravitreal, fully bio-erodible PRINT-manufactured implant that releases steroid dexamethasone. Aerie Pharmaceuticals, an ophthalmic pharmaceutical c...
Read More >>KEYTRUDA® combination significantly improved overall survival in adults with metastatic squamous NSCLC Its safety in combination ...
Read More >>The regulator reviewed the manufacturing and testing practices of India-based Alkem Laboratories Limited and found no traces of impurity The United States Food and ...
Read More >>The new strategic partnership would see the two enterprises collaborate on the development & commercialization of digital therapeutics in crucial Asian markets. ...
Read More >>Almac One™ would help sponsors to face the challenges existing in the drug development market It provide a single set of process to sponsors and enabl...
Read More >>The five-year collaboration is expected to bring about financial improvement amounting to almost $100 million. GE Healthcare and Adventist Health, two of the most r...
Read More >>BioXcel Therapeutics, Inc. has made an announcement confirming the addition of Germany-based Merck KGaA as well as Pfizer Inc. to its clinical collaboration with Nektar Therapeutics for evaluating an innovative triple ...
Read More >>The study proves to offer clear or almost clear skin in 8/10 patients within 16 weeks of Cosentyx® 300mg treatment. Swiss pharmaceutical major, Novartis AG (NVS...
Read More >>The treatment would help to address unmet medical needs against serious skin lesions Reports suggest that the lead candidate of Verrica Pharmaceuticals, a drug-devi...
Read More >>Shanghai-based drug development firm Hua Medicine, which focuses on developing global first-in-class oral drug for treating Type 2 diabetes, has recently announced that it has completed patient enrollment for a Phase I...
Read More >>The firm is looking forward to its MSK collaborators’ clinical outcomes of a mesothelin-targeted autologous CAR T for patients suffering from advanced malignant pleural ailment &nbs...
Read More >>Both the companies will come up with holistic solutions for farmers, veterinarians, and the food producing industry. The partnership aims to develop a ...
Read More >>Sarepta Therapeutics has recently confirmed that it is planning to acquire Myonexus Therapeutics in a $165 million deal, by exercising a purchase option that was part of a gene therapy partnership commenced by the firm...
Read More >>Scholar Rock Holding Corporation, the clinical-stage biopharma company focusing on treating serious diseases which are affected by protein growth factors, has recently confirmed positive interim results for its Phase 1...
Read More >>California-based augmented reality (AR) glasses manufacturer, Ocutrx Vision Technologies, LLC, has recently unveiled its new, cutting-edge design for Oculenz™ AR Wear glasses, which is the company’s flagshi...
Read More >>Morphic has attained leadership position in the development of oral integrin inhibitors with the help of the ground-breaking structural research Morphic Therapeutic...
Read More >>AzurRx BioPharma, Inc. has recently informed that the company has dosed the first patients in its Phase II OPTION clinical study aimed at investigating MS1819-SD in cystic fibrosis (CF) patients who experience exocrine...
Read More >>The company said its launch of an authorize generic version of the drug would prompt other firms to introduce their own cheaper versions The announ...
Read More >>Reports confirm that the Philippines has revoked the product license for Dengvaxia, the dengue vaccine from Sanofi, after the France-based pharmaceutical company failed to comply with directives of regulators. Apparently...
Read More >>The firm previously secured greater China rights to ZEVALIN® from Spectrum and aims to launch ZEVALIN® in the country. CASI Pharmaceutical...
Read More >>The FASST clinical trial failed to meet its primary endpoint of a mean absolute change from baseline to week 48 The French clinical-stage biopharmaceutical firm Inv...
Read More >>Pharmaceutical major Merck & Co Inc., has apparently announced the launch of three late-stage studies for KEYTRUDA – its cancer immunotherapy. Trusted reports cite that these studies are being introduced as a...
Read More >>Jubilant will deliver Sanofi drug discovery services with its integrated drug discovery platform. The Bengaluru-based arm of the reputed Jubilant Life Sciences, Jub...
Read More >>© 2024 IntelligenceJournal.com. All Rights Reserved.